Also trades as: 3349.T (JPX) · $vol 16M

$40.45

+0.00 (+0.00%)

OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Buy · Power 69 · $3.2B mcap · 41M float · 0.0000% daily turnover · Short 100% of daily vol

Revenue

$1.10T +8.8% ▲

5Y CAGR: +8.7%

Gross Profit

$229.9B +7.8% ▲

5Y CAGR: +9.6%

Operating Income

$42.4B +4.9% ▲

5Y CAGR: +5.0%

Net Income

$32.1B +3.5% ▲

5Y CAGR: +3.4%

EPS (Diluted)

$405.05 +3.6% ▲

5Y CAGR: -10.0%

EBITDA

$67.0B +3.3% ▲

5Y CAGR: +5.0%

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$755.4B	$827.7B	$965.0B	$1.01T	$1.10T
YoY Growth	+4.0%	+9.6%	+16.6%	+4.8%	+8.8%
Cost of Revenue	$604.0B	$659.0B	$776.7B	$798.1B	$870.8B
Gross Profit	$151.4B	$168.7B	$188.3B	$213.3B	$229.9B
Gross Margin	20.0%	20.4%	19.5%	21.1%	20.9%
R&D Expenses	$0	$0	$0	$0	$0
SG&A Expenses	$107.8B	$122.8B	$1.9B	$0	$187.5B
Operating Expenses	$121.7B	$138.6B	$156.8B	$172.9B	$187.5B
Operating Income	$29.8B	$30.1B	$31.5B	$40.4B	$42.4B
Operating Margin	3.9%	3.6%	3.3%	4.0%	3.9%
Interest Expense	$52M	$51M	$99M	$254M	$582M
Income Before Tax	$33.0B	$32.8B	$33.7B	$42.4B	$44.3B
Tax Expense	$9.9B	$9.0B	$9.3B	$11.4B	$12.2B
Net Income	$23.2B	$23.8B	$24.5B	$31.0B	$32.1B
Net Margin	3.1%	2.9%	2.5%	3.1%	2.9%
EPS (Diluted)	$584.74	$600.95	$308.61	$390.86	$405.05
EBITDA	$48.2B	$50.2B	$53.7B	$64.9B	$67.0B
Shares Outstanding	40M	40M	79M	79M	79M

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$261.8B	$244.1B	$246.3B	$259.1B	$272.1B	$264.3B	$274.0B	$289.5B
Cost of Revenue	$207.3B	$192.6B	$193.2B	$205.0B	$215.0B	$208.7B	$216.8B	$229.7B
Gross Profit	$54.6B	$51.5B	$53.1B	$54.1B	$57.1B	$55.6B	$57.2B	$59.8B
Gross Margin	20.8%	21.1%	21.6%	20.9%	21.0%	21.0%	20.9%	20.7%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$43.1B	$42.6B	$42.2B	$24.5B	$45.5B	$46.6B	$45.8B	$49.5B
Operating Expenses	$43.0B	$42.7B	$41.9B	$45.3B	$45.5B	$46.6B	$45.8B	$49.5B
Operating Income	$11.6B	$8.8B	$11.3B	$8.8B	$11.6B	$9.0B	$11.4B	$10.3B
Operating Margin	4.4%	3.6%	4.6%	3.4%	4.3%	3.4%	4.2%	3.6%
Interest Expense	$38M	$37M	$34M	$109M	$110M	$107M	$107M	$257M
Income Before Tax	$12.1B	$9.4B	$11.7B	$9.2B	$12.1B	$9.6B	$12.0B	$10.6B
Tax Expense	$3.9B	$3.1B	$3.8B	$551M	$3.9B	$3.1B	$3.9B	$1.3B
Net Income	$8.1B	$6.3B	$7.9B	$8.6B	$8.2B	$6.5B	$8.1B	$9.3B
Net Margin	3.1%	2.6%	3.2%	3.3%	3.0%	2.4%	3.0%	3.2%
EPS (Diluted)	$102.74	$79.30	$99.86	$108.95	$103.00	$81.58	$101.76	$118.01
EBITDA	$16.4B	$14.2B	$15.9B	$15.3B	$17.9B	$15.6B	$17.6B	$17.0B
Shares Outstanding	79M	79M	79M	79M	79M	79M	79M	79M

CSMYF OTC